William R. Berry

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2019 · 364 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer

Howard I. Scher, Xiaoyu Jia, Kim Chi et al. · Journal of Clinical Oncology · 2011 · 250 citations · Full text

Medicine, Oncology, Pharmacology +16

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Guru Sonpavde, Phillip Periman, D. M. Bernold et al. · Annals of Oncology · 2009 · 137 citations · Full text

Medicine, Oncology, Pharmacology +14

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy

Guru Sonpavde, Gregory R. Pond, William R. Berry et al. · Urologic Oncology Seminars and Original Investigations · 2010 · 123 citations

Medicine, Oncology, Urology +12

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

Dana E. Rathkopf, Matthew R. Smith, Charles J. Ryan et al. · Annals of Oncology · 2017 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14